NXL
Nexalin Technology, Inc. · NASDAQ
- Sector Health Technology
- Industry Medical Specialties
- Website nexalin.com
- Employees(FY) 6
- ISIN US65345B2016
Performance
-33.96%
1W
-54.84%
1M
+124.0%
3M
+89.19%
6M
+72.92%
YTD
-18.6%
1Y
Profile
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.
Technical Analysis of NXL 2024-05-31
Overview:
In analyzing the technical indicators for NXL over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement in the upcoming days. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to off...
Recent News & Updates
- 2022-09-20 01:12
- 2022-09-15 08:54
- 2022-04-10 06:52
What Kind Of Investors Own Most Of Nuix Limited (ASX:NXL)?(Yahoo Finance)
Page 2 of 2
previousnext